Longenesis - a Hong-Kong based company which offers the industry's most advanced life data escrow built on Exonum™ blockchain for security and powered by AI for traceability and smart data management.
longenesis logo

    • Leader in Artificial Intelligence for Drug Discovery, Biomarker Development and Aging Research
    • Attracted over $12 million in venture funding
    • NVIDIA's top 5 AI Companies for Social Impact
    • Over 200 research collaborators worldwide
    • Deals with big pharma companies
    • Over 40 peer-reviewed research publications
    • Projects Executed: Young.AI, Embryonic.AI,, Chemistry.AI,

    • The world's leading full-service blockchain technology company
    • Architect of the open-source blockchain framework Exonum
    • Bitcoin transaction processer, with data centers in Norway, Canada, Iceland and Georgia
    • Leading several blockchain projects around the world, including the Republic of Georgia, Ukraine, Bermuda and Malta
    • More than $100 million in venture equity and debt
    Baltimore, USA
    Amsterdam, Netherlands
    was formed as the result of two large companies partnering. Insilico Medicine brings the Artificial Intelligence. Bitfury Group provides its Exonum blockchain solution.

    Just by submitting information and regularly contributing data to Longenesis, users can sell their data to pharma companies. This creates a healthy circulation of life data.
    Sell your health data
    Use Case
    Our goal is to build a revolutionary platform that delivers the future of medicine and data analytics through integration of the best AI and Blockchain solutions available.
    By building and launching this platform on blockchain technology, we assure our users that their files are private and secure. Users can store and track their medical data to gain insight into their health like never before.
    Securely store data and track your health
    Utilization of smart contracts gives the buyer and seller a direct line of communication in a secure manner. Buyers can send data requests to Sellers without having to go through a human intermediary so the process can be streamlined. This allows buyers and sellers to communicate directly in a secure setting.
    Direct interaction without third parties
    Longenesis data escrow is able to provide new insights in the field of Healthcare R&D. It provides analysis and recommendations to pharmaceutical companies to help develop new drugs.
    Healthcare Development
    Nebula Genomics powered by Longenesis
    Application of artificial intelligence and blockchain technology creating a marketplace for individuals and biobanks to store, manage, and control access to genomic and other health data in a secure environment.
    New York, USA
    Alex Zhavoronkov, CSO, Longenesis
    Consensus 2018
    Singularity Exponential Medicine 2017
    South Korea
    San Diego, USA
    The Global Leaders Forum
    Alex Zhavoronkov, CEO, Insilico Medicine

    Valery Vavilov, Founder and CEO, Director of the Board, Bitfury
    Emil Syndyukov, CTO, Longenesis
    Malta Blockchain Summit 2018
    Contact us
    © 2018. All Rights Reserved. Longenesis Ltd.